Henry Schein (HSIC) Expected to Announce Earnings on Tuesday

Henry Schein (NASDAQ:HSIC) is expected to be releasing its Q3 2025 results before the market opens on Tuesday, November 4th. Analysts expect Henry Schein to post earnings of $1.27 per share and revenue of $3.2811 billion for the quarter. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS.Interested persons are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Tuesday, November 4, 2025 at 8:00 AM ET.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). The company had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business’s quarterly revenue was up 3.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.23 EPS. On average, analysts expect Henry Schein to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Henry Schein Stock Performance

NASDAQ HSIC opened at $63.20 on Monday. The firm has a 50-day moving average of $66.19 and a 200-day moving average of $68.56. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The stock has a market cap of $7.66 billion, a PE ratio of 20.39, a P/E/G ratio of 2.06 and a beta of 0.81. Henry Schein has a 52-week low of $60.56 and a 52-week high of $82.49.

Hedge Funds Weigh In On Henry Schein

Several hedge funds have recently bought and sold shares of the company. Ameriprise Financial Inc. increased its holdings in Henry Schein by 3,275.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company’s stock valued at $165,594,000 after buying an additional 2,199,695 shares during the period. Bank of America Corp DE increased its holdings in Henry Schein by 204.2% in the 2nd quarter. Bank of America Corp DE now owns 995,375 shares of the company’s stock valued at $72,712,000 after buying an additional 668,182 shares during the period. BNP Paribas Financial Markets increased its holdings in Henry Schein by 39.1% in the 2nd quarter. BNP Paribas Financial Markets now owns 408,360 shares of the company’s stock valued at $29,831,000 after buying an additional 114,750 shares during the period. First Trust Advisors LP increased its holdings in Henry Schein by 0.8% in the 2nd quarter. First Trust Advisors LP now owns 221,130 shares of the company’s stock valued at $16,154,000 after buying an additional 1,669 shares during the period. Finally, Zuckerman Investment Group LLC increased its holdings in Henry Schein by 3.8% in the 2nd quarter. Zuckerman Investment Group LLC now owns 209,299 shares of the company’s stock valued at $15,289,000 after buying an additional 7,660 shares during the period. 96.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

HSIC has been the subject of several analyst reports. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research note on Monday, July 14th. Evercore ISI upgraded shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 price objective for the company in a research note on Tuesday, August 26th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Henry Schein in a research note on Friday. UBS Group dropped their price objective on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research note on Wednesday, August 6th. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Five investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, Henry Schein presently has an average rating of “Hold” and a consensus target price of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.